Logo image of XIL.PA

XILAM ANIMATION (XIL.PA) Stock Fundamental Analysis

EPA:XIL - Euronext Paris - Matif - FR0004034072 - Common Stock - Currency: EUR

2.32  -0.02 (-0.85%)

Fundamental Rating

4

Taking everything into account, XIL scores 4 out of 10 in our fundamental rating. XIL was compared to 46 industry peers in the Entertainment industry. XIL has an average financial health and profitability rating. XIL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year XIL was profitable.
In the past year XIL had a positive cash flow from operations.
Each year in the past 5 years XIL has been profitable.
Each year in the past 5 years XIL had a positive operating cash flow.
XIL.PA Yearly Net Income VS EBIT VS OCF VS FCFXIL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

XIL has a Return On Assets (1.89%) which is in line with its industry peers.
With a Return On Equity value of 3.24%, XIL perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.06%, XIL is in line with its industry, outperforming 56.52% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for XIL is below the industry average of 8.15%.
Industry RankSector Rank
ROA 1.89%
ROE 3.24%
ROIC 1.06%
ROA(3y)3%
ROA(5y)3.39%
ROE(3y)6.45%
ROE(5y)7.23%
ROIC(3y)3.87%
ROIC(5y)4.42%
XIL.PA Yearly ROA, ROE, ROICXIL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

XIL's Profit Margin of 7.22% is fine compared to the rest of the industry. XIL outperforms 69.57% of its industry peers.
In the last couple of years the Profit Margin of XIL has declined.
The Operating Margin of XIL (3.97%) is better than 60.87% of its industry peers.
XIL's Operating Margin has declined in the last couple of years.
The Gross Margin of XIL (94.77%) is better than 86.96% of its industry peers.
XIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.97%
PM (TTM) 7.22%
GM 94.77%
OM growth 3Y-18.09%
OM growth 5Y-18.03%
PM growth 3Y-1.29%
PM growth 5Y-11.45%
GM growth 3Y-0.6%
GM growth 5Y-0.81%
XIL.PA Yearly Profit, Operating, Gross MarginsXIL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XIL is destroying value.
The number of shares outstanding for XIL has been reduced compared to 1 year ago.
XIL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for XIL has been reduced compared to a year ago.
XIL.PA Yearly Shares OutstandingXIL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
XIL.PA Yearly Total Debt VS Total AssetsXIL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that XIL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.20, XIL perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
XIL has a debt to FCF ratio of 1.08. This is a very positive value and a sign of high solvency as it would only need 1.08 years to pay back of all of its debts.
The Debt to FCF ratio of XIL (1.08) is better than 89.13% of its industry peers.
XIL has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of XIL (0.09) is better than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.08
Altman-Z 1.2
ROIC/WACC0.22
WACC4.87%
XIL.PA Yearly LT Debt VS Equity VS FCFXIL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

XIL has a Current Ratio of 0.81. This is a bad value and indicates that XIL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of XIL (0.81) is comparable to the rest of the industry.
XIL has a Quick Ratio of 0.81. This is a bad value and indicates that XIL is not financially healthy enough and could expect problems in meeting its short term obligations.
XIL has a Quick ratio (0.81) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
XIL.PA Yearly Current Assets VS Current LiabilitesXIL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

3

3. Growth

3.1 Past

XIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 444.63%, which is quite impressive.
XIL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.01% yearly.
Looking at the last year, XIL shows a very negative growth in Revenue. The Revenue has decreased by -16.46% in the last year.
The Revenue has been growing by 13.12% on average over the past years. This is quite good.
EPS 1Y (TTM)444.63%
EPS 3Y26.54%
EPS 5Y-1.01%
EPS Q2Q%-143.34%
Revenue 1Y (TTM)-16.46%
Revenue growth 3Y28.27%
Revenue growth 5Y13.12%
Sales Q2Q%-36.15%

3.2 Future

Based on estimates for the next years, XIL will show a very negative growth in Earnings Per Share. The EPS will decrease by -68.54% on average per year.
The Revenue is expected to decrease by -22.90% on average over the next years. This is quite bad
EPS Next Y-279.77%
EPS Next 2Y-63.97%
EPS Next 3Y-68.54%
EPS Next 5YN/A
Revenue Next Year-44.9%
Revenue Next 2Y-37.86%
Revenue Next 3Y-22.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XIL.PA Yearly Revenue VS EstimatesXIL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
XIL.PA Yearly EPS VS EstimatesXIL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 -1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.38, the valuation of XIL can be described as very cheap.
XIL's Price/Earnings ratio is rather cheap when compared to the industry. XIL is cheaper than 93.48% of the companies in the same industry.
XIL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.90.
The Forward Price/Earnings Ratio is negative for XIL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 4.38
Fwd PE N/A
XIL.PA Price Earnings VS Forward Price EarningsXIL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XIL indicates a rather cheap valuation: XIL is cheaper than 97.83% of the companies listed in the same industry.
97.83% of the companies in the same industry are more expensive than XIL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.08
EV/EBITDA 1.09
XIL.PA Per share dataXIL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as XIL's earnings are expected to decrease with -68.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.97%
EPS Next 3Y-68.54%

0

5. Dividend

5.1 Amount

XIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XILAM ANIMATION

EPA:XIL (3/14/2025, 7:00:00 PM)

2.32

-0.02 (-0.85%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)03-27 2025-03-27/amc
Inst Owners16.63%
Inst Owner ChangeN/A
Ins Owners42.61%
Ins Owner ChangeN/A
Market Cap13.66M
Analysts48.89
Price Target3.57 (53.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-39.66%
PT rev (3m)-39.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-670%
EPS NY rev (3m)-670%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.34%
Revenue NY rev (3m)-10.34%
Valuation
Industry RankSector Rank
PE 4.38
Fwd PE N/A
P/S 0.41
P/FCF 1.08
P/OCF 0.56
P/B 0.18
P/tB N/A
EV/EBITDA 1.09
EPS(TTM)0.53
EY22.84%
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)2.15
FCFY92.72%
OCF(TTM)4.17
OCFY179.67%
SpS5.63
BVpS12.57
TBVpS-2.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.89%
ROE 3.24%
ROCE 1.44%
ROIC 1.06%
ROICexc 1.14%
ROICexgc N/A
OM 3.97%
PM (TTM) 7.22%
GM 94.77%
FCFM 38.2%
ROA(3y)3%
ROA(5y)3.39%
ROE(3y)6.45%
ROE(5y)7.23%
ROIC(3y)3.87%
ROIC(5y)4.42%
ROICexc(3y)4.31%
ROICexc(5y)5.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.27%
ROCE(5y)6.14%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y4.61%
ROICexc growth 5Y-13.89%
OM growth 3Y-18.09%
OM growth 5Y-18.03%
PM growth 3Y-1.29%
PM growth 5Y-11.45%
GM growth 3Y-0.6%
GM growth 5Y-0.81%
F-Score7
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.08
Debt/EBITDA 0.36
Cap/Depr 67.82%
Cap/Sales 35.83%
Interest Coverage 1.26
Cash Conversion 130.36%
Profit Quality 528.8%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 1.2
F-Score7
WACC4.87%
ROIC/WACC0.22
Cap/Depr(3y)103.9%
Cap/Depr(5y)123.53%
Cap/Sales(3y)79.53%
Cap/Sales(5y)92.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)444.63%
EPS 3Y26.54%
EPS 5Y-1.01%
EPS Q2Q%-143.34%
EPS Next Y-279.77%
EPS Next 2Y-63.97%
EPS Next 3Y-68.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.46%
Revenue growth 3Y28.27%
Revenue growth 5Y13.12%
Sales Q2Q%-36.15%
Revenue Next Year-44.9%
Revenue Next 2Y-37.86%
Revenue Next 3Y-22.9%
Revenue Next 5YN/A
EBIT growth 1Y531.15%
EBIT growth 3Y5.07%
EBIT growth 5Y-7.27%
EBIT Next Year148.39%
EBIT Next 3Y60.9%
EBIT Next 5YN/A
FCF growth 1Y329.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.96%
OCF growth 3Y10.75%
OCF growth 5Y10.32%